GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED

Altre lingue Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Shanghai S.E.

Azioni

600332

CNE000001733

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 28/06/2024			Variaz. 5gg	Var. 1 gen.
29,33 ^CNY	+0,34%		-0,54%	+2,55%

27/06	Guangzhou Baiyunshan Pharmaceutical ottiene la registrazione del farmaco per le compresse per la disfunzione erettile	MT
19/06	L'unità di Baiyunshan Pharmaceutical ottiene il consenso normativo per l'aggiunta di specifiche per l'iniezione di cloridrato di dopamina	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Guangzhou Baiyunshan Pharmaceutical Secures Drug Registration for Erectile Dysfunction Tablets	27/06
Baiyunshan Pharmaceutical's Unit Gets Regulatory Nod to Add Specification for Dopamine Hydrochloride Injection	19/06
Baiyunshan Pharmaceutical's Unit Gets Nod from Macao's Drug Regulator to Import, Export Pearl Powder	17/06
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Baiyunshan Pharmaceutical's 2023 Profit Rises 2%	18/03
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Proposes Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024	15/03
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Baiyunshan Pharma's Unit Gets Green Light to Produce Hepatitis B Drug	01/03
Guangzhou Pharma Unit Gets Green Light to Trial Oral Liquid Drug	09/02
Guangzhou Baiyunshan Pharmaceutical Arm Floats 1 Billion Yuan Biomedical VC Fund	19/12
Guangzhou Baiyunshan Pharmaceutical Ends Spin-Off Plans, Seeks China Listing for Subsidiary	19/12
Guangzhou Pharma Expands Scope of Drug Production License	13/11
Guangzhou Baiyunshan Pharmaceutical's Profit Up 11% in Q3	30/10/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Baiyunshan Pharmaceutical Reports Increase in H1 Attributable Profit	13/09/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	17/08/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(SHSE:600332) added to Shanghai Stock Exchange 180 Value Index	12/06/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(SHSE:600332) added to SSE 180 Index	12/06/23
Guangzhou Pharma Registers Pain-Relief, Anti-Inflammatory Drugs in Russia	26/05/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 30, 2023	27/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Shanghai S.E.

Azioni

600332

CNE000001733

Altre lingue

Filtri